2022 Annual Meeting

Session: Advances in Drug Discovery Processes (including HTE): Protein Engineering Approaches with Target Therapeutic Applications

Chair

Co-Chair

Presentations

12:30 PM

(640a) Intelligent High-Throughput Intervention Testing Platform in Daphnia

12:51 PM

(640b) Cellular Proton Motive Force: A Therapeutic Target for Eradicating Methicillin-Resistant Staphylococcus Aureus Persister Cells

01:12 PM

(640c) Identification of Apolipoprotein E4 Inhibitors for Alzheimer’s Disease Therapy through Large-Scale Virtual Screening

01:33 PM

(640d) Polymer Lung Surfactant: A First-in-Class Synthetic Surfactant Therapeutic for Acute Respiratory Distress Syndrome (ARDS)

01:54 PM

(640e) An Innovative Therapeutic Fusion Protein Approach for Chronic Wound Healing

02:15 PM

(640f) Peg-Conjugated Extracellular Mega-Hemoglobin for Diverse Oxygen Therapeutic Applications